PMID: 3758143Jan 1, 1986Paper

Evaluation of once daily endralazine in hypertension

European Journal of Clinical Pharmacology
R WuS G Carruthers

Abstract

Endralazine, a novel vasodilator related to hydralazine, exhibits a longer half-life and is only minimally influenced by acetylator status. The antihypertensive action of once daily endralazine has been studied in 17 patients previously controlled with an antihypertensive regimen which included hydralazine and a beta-blocker. Hydralazine was discontinued but other medications were unchanged. Pre-study dosage of hydralazine ranged from 25 mg b.i.d. to 50 mg g.i.d., mean daily dose 126.5 mg. Endralazine was started at a dose of 10 mg o.d. and increased by 10 mg to a maximum of 40 mg o.d. until seated DBP was controlled below 95 mmHg. All 17 patients completed the study. Seated BP significantly decreased from 147.5/99.7 to 133.8/83.9 and standing BP from 145.8/99.2 to 133.6/87.3 mmHg. Ten patients (59%) were successfully controlled with endralazine once daily but 7 patients required twice daily dosage schedules because of lack of BP control at 24 h after dosing or excessive hypotension shortly after dosing. Other adverse effects were headache, palpitations and fatigue. There was a statistically insignificant average weight gain of 1 kg but pedal edema was not observed. Endralazine is an effective antihypertensive agent with advers...Continue Reading

References

Mar 2, 1985·British Medical Journal·M DohertyR H Grey
Jun 1, 1973·Circulation·B D KosowskyR F Ritchie
Mar 2, 1967·The New England Journal of Medicine·J J CondemiH M Perry
Sep 10, 1983·Lancet·M D Donaldson, T L Chambers
Jul 1, 1982·Journal of Cardiovascular Pharmacology·W Kirch, T Axthelm
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·H L ElliottJ L Reid
Mar 27, 1982·British Medical Journal·R Mansilla-TinocoJ M Jones
May 29, 1982·British Medical Journal·J H SilasS Freestone
Jan 1, 1983·European Journal of Clinical Pharmacology·W A Bogers, L Meems
Jul 1, 1983·British Journal of Clinical Pharmacology·P A MeredithJ L Reid
Dec 1, 1982·Postgraduate Medical Journal·E R HiggsJ C Mackenzie
Jan 1, 1982·European Journal of Clinical Pharmacology·P A ReeceR Zacest
Apr 1, 1981·British Journal of Clinical Pharmacology·V Facchini, J A Timbrell
Dec 1, 1980·Clinical Pharmacology and Therapeutics·P A ReeceR Zacest
Mar 1, 1981·Clinical Pharmacology and Therapeutics·J A TimbrellV Facchini

❮ Previous
Next ❯

Citations

Jan 1, 1988·Toxicology in Vitro : an International Journal Published in Association with BIBRA·R Bechter, H Schön

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.